World’s first whole-eye and partial face transplant recipient is doing well
HQ Team September 10, 2024: Aaron James, 46, the first-ever person to undergo a combined whole-eye and partial face transplant, is doing well
HQ Team September 10, 2024: Aaron James, 46, the first-ever person to undergo a combined whole-eye and partial face transplant, is doing well
People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing
Sudan’s civil war is a “nightmare” and the World Health Organization has called on the international community to broker peace and provide the
EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to
Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%,
India suspects a young male to be infected with mpox after he travelled to a country currently in the grip of the disease,
September 6, 2024: UK pharmaceutical giant GSK (GSK.L) announced that its asthma medicine, Nucala (mepolizumab), has shown positive results in a late-stage clinical
HQ Team September 6, 2024: The National Medical Products Administration (NMPA) of China has suspended the import, sale, and use of Dr Reddy’s
Harvard Medical School scientists have designed an artificial intelligence model similar to ChatGPT that detects cancer or predicts a tumour’s genetic profile.